Drreddys Laboratories | RDY - Betriebsergebnis





Betriebsergebnis Veränderung Datum
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bayer EUR 3.53B 2.42B 2026-03
Canopy Growth CAD -12.66M 1.64M 2025-12
Cipla INR 6.14B 3.63B 2026-03
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Drreddys Laboratories INR 14.33B 2.51B 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Novartis USD 4.24B 171M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Richter Gedeon HUF 63.58B 6.08B 2025-09
Sun Pharmaceuticals INR 40.62B 6.95B 2025-12
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03